These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25014771)

  • 1. A decade of modelling drug release from arterial stents.
    McGinty S
    Math Biosci; 2014 Nov; 257():80-90. PubMed ID: 25014771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving smooth muscle cell exposure to drugs from drug-eluting stents at early time points: a variable compression approach.
    O'Connell BM; Cunnane EM; Denny WJ; Carroll GT; Walsh MT
    Biomech Model Mechanobiol; 2014 Aug; 13(4):771-81. PubMed ID: 24101254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Numerical modelling of mass transport in an arterial wall with anisotropic transport properties.
    Denny WJ; Walsh MT
    J Biomech; 2014 Jan; 47(1):168-77. PubMed ID: 24210470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mathematical model for predicting drug release from a biodurable drug-eluting stent coating.
    Hossainy S; Prabhu S
    J Biomed Mater Res A; 2008 Nov; 87(2):487-93. PubMed ID: 18186043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-eluting stents versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of early outcomes from randomized and nonrandomized studies.
    Cao C; Manganas C; Bannon P; Vallely M; Yan TD
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):738-47. PubMed ID: 22405674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug eluting devices for critically ill patients: can we apply lessons learned from the treatment of peripheral artery disease?
    Werner M; Scheinert D
    Adv Drug Deliv Rev; 2014 Nov; 77():32-9. PubMed ID: 25049084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A general model of coupled drug release and tissue absorption for drug delivery devices.
    McGinty S; Pontrelli G
    J Control Release; 2015 Nov; 217():327-36. PubMed ID: 26390809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mussel inspired coating of a biocompatible cyclodextrin based polymer onto CoCr vascular stents.
    Sobocinski J; Laure W; Taha M; Courcot E; Chai F; Simon N; Addad A; Martel B; Haulon S; Woisel P; Blanchemain N; Lyskawa J
    ACS Appl Mater Interfaces; 2014 Mar; 6(5):3575-86. PubMed ID: 24533838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
    Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lesions in small coronary vessels disease: should drug-coated balloons replace drug-eluting stents as the treatment of choice?
    Byrne RA; Kastrati A
    EuroIntervention; 2011 May; 7 Suppl K():K47-52. PubMed ID: 22027727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stents for coronary artery disease: a review.
    Martin DM; Boyle FJ
    Med Eng Phys; 2011 Mar; 33(2):148-63. PubMed ID: 21075668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug release from coronary eluting stents: A multidomain approach.
    Vairo G; Cioffi M; Cottone R; Dubini G; Migliavacca F
    J Biomech; 2010 May; 43(8):1580-9. PubMed ID: 20185137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting biostable and erodible stents.
    Huang Y; Ng HC; Ng XW; Subbu V
    J Control Release; 2014 Nov; 193():188-201. PubMed ID: 24845127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release profiles in drug-eluting stents: issues and uncertainties.
    Venkatraman S; Boey F
    J Control Release; 2007 Jul; 120(3):149-60. PubMed ID: 17582635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro release profiles of drug-eluting controlled biodegradable polymer coating stents.
    Pan CJ; Tang JJ; Weng YJ; Wang J; Huang N
    Colloids Surf B Biointerfaces; 2009 Oct; 73(2):199-206. PubMed ID: 19541460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling drug-eluting stents.
    McGinty S; McKee S; Wadsworth RM; McCormick C
    Math Med Biol; 2011 Mar; 28(1):1-29. PubMed ID: 20413417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries.
    Speck U; Scheller B; Abramjuk C; Breitwieser C; Dobberstein J; Boehm M; Hamm B
    Radiology; 2006 Aug; 240(2):411-8. PubMed ID: 16864669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-vascular drug eluting stents as localized controlled drug delivery platform: preclinical and clinical experience.
    Shaikh M; Kichenadasse G; Choudhury NR; Butler R; Garg S
    J Control Release; 2013 Nov; 172(1):105-117. PubMed ID: 23958902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local drug delivery for percutaneous coronary intervention.
    Sharma S; Christopoulos C; Kukreja N; Gorog DA
    Pharmacol Ther; 2011 Mar; 129(3):260-6. PubMed ID: 21111759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some design considerations for polymer-free drug-eluting stents: a mathematical approach.
    McGinty S; Vo TTN; Meere M; McKee S; McCormick C
    Acta Biomater; 2015 May; 18():213-225. PubMed ID: 25712386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.